SavedAdd your journal

Journals / ENT Updates / 2016 / Cilt: 6 - Sayı: 2

Clinical and histopathological presentations of sinonasal cancers in Komfo Anokye Teaching Hospital

Komfo Anokye Eğitim Hastanesinde sinonazal kanserlerin klinik ve histopatolojik özellikleri

Joseph OPOKU-BUABENG
Seth ACQUAH
Pages
87–90
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion:Sinonasal tumors are frequent in male adults and present with epistaxis, nasal mass, blocked nose and nasal discharge, whilesquamous cell carcinoma remains the common histopathologicaltype

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective:To determine the incidence, clinical and histopathological presentations of the paranasal sinus tumors in Komfo AnokyeTeaching Hospital, Kumasi, Ghana.Methods:All cases of sinonasal cancers diagnosed between January2007 and December 2012 were retrospectively reviewed.Results: Of the 68 patients (38 males, 30 females) whose charts werereviewed, the median age was 49 (range: 14 to 84) years.
📊
Key Findings & Data:The commonclinical presentations were epistaxis (23%), nasal mass (20%), headache(12%), nasal blockage (12%), nasal discharge (11%), proptosis (9%),cheek swelling (8%), and epiphora (5%).
💡
Conclusion & Impact:Conclusion:Sinonasal tumors are frequent in male adults and present with epistaxis, nasal mass, blocked nose and nasal discharge, whilesquamous cell carcinoma remains the common histopathologicaltype
🔬Design:Review & Systematic Survey
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective:To determine the incidence, clinical and histopathological presentations of the paranasal sinus tumors in Komfo AnokyeTeaching Hospital, Kumasi, Ghana.Methods:All cases of sinonasal cancers diagnosed between January2007 and December 2012 were retrospectively reviewed.Results: Of the 68 patients (38 males, 30 females) whose charts werereviewed, the median age was 49 (range: 14 to 84) years. The commonclinical presentations were epistaxis (23%), nasal mass (20%), headache(12%), nasal blockage (12%), nasal discharge (11%), proptosis (9%),cheek swelling (8%), and epiphora (5%). The most commonhistopathological subtypes were squamous cell carcinoma (39.6%) andadenocarcinoma (25%). Conclusion:Sinonasal tumors are frequent in male adults and present with epistaxis, nasal mass, blocked nose and nasal discharge, whilesquamous cell carcinoma remains the common histopathologicaltype

Özet

Objective:To determine the incidence, clinical and histopathological presentations of the paranasal sinus tumors in Komfo AnokyeTeaching Hospital, Kumasi, Ghana.Methods:All cases of sinonasal cancers diagnosed between January2007 and December 2012 were retrospectively reviewed.Results: Of the 68 patients (38 males, 30 females) whose charts werereviewed, the median age was 49 (range: 14 to 84) years. The commonclinical presentations were epistaxis (23%), nasal mass (20%), headache(12%), nasal blockage (12%), nasal discharge (11%), proptosis (9%),cheek swelling (8%), and epiphora (5%). The most commonhistopathological subtypes were squamous cell carcinoma (39.6%) andadenocarcinoma (25%). Conclusion:Sinonasal tumors are frequent in male adults and present with epistaxis, nasal mass, blocked nose and nasal discharge, whilesquamous cell carcinoma remains the common histopathologicaltype

🔖

Cite This Article

OPOKU-BUABENG, J., ACQUAH, S. (2022). Clinical and histopathological presentations of sinonasal cancers in Komfo Anokye Teaching Hospital. ENT Updates, Cilt: 6 - Sayı: 2, 87–90. https://ajindex.com/articles/501422

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kuijpens JHLP, Louwman MWJ, Peters R, Janssens GORJ, Burdorf AL, Coebergh JWW. Trends in sinonasal cancer in The Netherlands: more squamous cell cancer, less adenocarcinoma. A population-based study 1973-2009. Eur J Cancer 2012;48: 2369–74
  2. Myers LL, Nussenbaum B, Bradford CR, Teknos TN, Esclamado RM, Wolf GT. Paranasal sinus malignances: an 18- year single institution experience. Laryngoscope 2002;112:1964– 9
  3. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92: 3012–29
  4. Weber AL. Tumors of the paranasal sinuses. Otolaryngol Clin North Am 1988;21:439–54
  5. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231–6
  6. Arnold A, Ziglinas P, Ochs K, et al. Therapy options and longterm results of sinonasal malignancies. Oral Oncol 2012;48: 1031–7
  7. Betlejewski S, Bilewicz R, Stankiewicz C, et al. Malignant tumours of the nose and paranasal sinuses in the years 1992–2001. [Article in Polish] Otolaryngol Pol 2006;60:729–36
  8. Fasunla AJ, Lasisi AO. Sinonasal malignancies: a 10-year review in a tertiary health institution. J Natl Med Assoc 2007;99:1407– 10
  9. Brobby GW. Cancer of the maxillary sinus and its management in Kumasi, Ghana. Journal of the University of Science and Technology (Kumasi) 1988;8:1–6
  10. Myers LL, Oxford LE. Differential diagnosis and treatment options in paranasal sinus cancers. Surg Oncol Clin North Am 2004;13:167–86
  11. Koivunen P, Mäkitie AA, Bäck L, et al. A national series of 244 sinonasal cancers in Finland in 1990–2004. Eur Arch Otorhinolaryngol 2012;269:615–21
  12. Waldron JN, O’Sullivan B, Gullane P, et al. Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 2000;57:167–73
  13. Madison Michael L 2nd, Sorenson JM, Samant S, Robertson JH. The treatment of advanced sinonasal malignancies with preoperative intra-arterial cisplatin and concurrent radiation. J Neurooncol 2005;72:67–75
  14. Zyłka S, Bień S, Kamiński B, Postuła S, Ziołkowska M. Epidemiology and clinical characteristics of sinonasal malignancies. [Article in Polish] Otolaryngol Pol 2008;62:436–41
  15. Carrau RL, Myers EM, Johnson JT. Paranasal sinus carcinoma – diagnosis, treatment and prognosis. Oncology (Williston Park) 1992;6:43–50; discussion 55–6.